Search
for
Sort by
Research 781–810 of 1000+
- Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study
- Bridging the organoid translational gap: integrating standardization and micropatterning for drug screening in clinical and pharmaceutical medicine
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- In Vitro and In Vivo Assessment of Metabolic Drug Interaction Potential of Dutasteride with Ketoconazole
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Recent Insights into the Potential and Challenges of Sericin as a Drug Delivery Platform for Multiple Biomedical Applications
- Highly flexible and controllable hierarchical MOF membrane for efficient drug release
- Retrospective analysis of smell and taste disturbances associated with dermatologic medications reported to the United States Food and Drug Administration and relevance to COVID-19 infections
- Physiological and histological study of the effect of finasteride drug (Prostacare) on the fertility of albino male rats
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Potent Efficacy of Computer-Aided Designed Peptide Degrader Drug on PCSK9-Mediated Hypercholesterolemia
- The Bioengineering of Microspheric Skin Organoids and Their Application in Drug Screening
- Microscopic identification of the remnant hair or feather of five animal drug components in Shenrongbian pill
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- Progress in the design of ascorbic acid derivative-mediated drug delivery
- Social Interest Data as a Proxy for Off-Label Performance-Enhancing Drug Use: Implications and Clinical Considerations
- Analysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database
- Leflunomide: an unlikely trigger and mechanistically a beneficial drug for alopecia areata
- Tumor necrosis factor-alpha inhibitor associated psoriasiform alopecia (drug-induced psoriasiform alopecia)
- A Need for Government Intervention? Prescription Drug Prices and Retail Mark-Ups
- TREATMENT OF SEVERE ALOPECIA AREATA USING METHOTREXATE AS AN ADJUNCTIVE DRUG IN COMBINATION WITH INTRAVENOUS AND ORAL CORTICOSTEROID
- Self-adaptive nanozymes with enhanced multi-enzyme activities for sequential multimodal therapy of drug-resistant bacteria-infected wounds
- Bio-inspired suction cup microneedle loaded fusion membrane targeting nano-drug delivery system treat androgenetic alopecia
- Case report of Esophagus Squamous Cell Carcinoma treated with Novel Drug Preparation Method of Catheranthus rosea (Periwinkle) - An Integrated Oncological approach
- Female Serum HER2 Expression: Its Association With Metabolic Syndrome and Treatment Drug Response
- Using a Natural Clay Mineral as an Active Drug Carrier to Promote Hair Growth
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Dutasteride infusion in male androgenetic alopecia using a novel drug delivery technique: MMP®
- Nanospanlastic vesicles as novel strategies for enhancing anti-glaucoma drug bioavailability
- Characterisation of Myotonic Dystrophy type I cell models and drug evaluation by a cell- based quantification platform.